• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

继发性闭经(作者译)

[Secondary amenorrhoea (author's transl)].

作者信息

Peters F, Richter D, Breckwoldt M

出版信息

Dtsch Med Wochenschr. 1978 May 26;103(21):898-902. doi: 10.1055/s-0028-1104784.

DOI:10.1055/s-0028-1104784
PMID:348436
Abstract

27 patients with secondary amenorrhoea for 6--20 months were investigated with a gonadorelin (GnRH-)test and a psychoanalytical exploration. Results, which were determined independently of each other, were then correlated. According to the gonadorelin and the gestagen test patients could be allocated to four groups: test group 1 = negative gestagen test, LH peak below 8 ng/ml, test group 2 = positive gestagen test, LH peak below 8 ng/ml, test group 3 = positive gestagen test, LH peak 8--20 ng/ml, test group 4 = positive gestagen test, LH peak 20--37 ng/ml. According to the psychoanalytical exploration two groups of patients could be differentiated. Patients of test group 1 and 2 showed psychosomatic disorders to a greater extent with pronounced associated somatic symptoms and predominantly retentive personality structures. Patients in test groups 3 and 4 showed predominantly associated mental symptoms accompanied by better insight into their own conflicts.

摘要

对27例继发性闭经6至20个月的患者进行了促性腺激素释放激素(GnRH)试验和精神分析探索。然后将相互独立确定的结果进行关联分析。根据促性腺激素释放激素和孕激素试验,患者可分为四组:试验组1 = 孕激素试验阴性,促黄体生成素(LH)峰值低于8 ng/ml;试验组2 = 孕激素试验阳性,LH峰值低于8 ng/ml;试验组3 = 孕激素试验阳性,LH峰值8至20 ng/ml;试验组4 = 孕激素试验阳性,LH峰值20至37 ng/ml。根据精神分析探索,可将患者分为两组。试验组1和2的患者在更大程度上表现出身心障碍,伴有明显的相关躯体症状,且主要具有滞留型人格结构。试验组3和4的患者主要表现出相关的精神症状,同时对自身冲突有更好的洞察力。

相似文献

1
[Secondary amenorrhoea (author's transl)].继发性闭经(作者译)
Dtsch Med Wochenschr. 1978 May 26;103(21):898-902. doi: 10.1055/s-0028-1104784.
2
[Estrogen provocation test as a supplement to the gonadotropin-releasing hormone test in secondary amenorrhea].[雌激素激发试验作为继发性闭经中促性腺激素释放激素试验的补充]
Akush Ginekol (Sofiia). 1980;19(5-6):541-3.
3
[Functional and hormonal differences between group I and group II amenorrhoea (WHO classification) (author's transl)].I型和II型闭经(世界卫生组织分类法)之间的功能及激素差异(作者译)
Wien Klin Wochenschr. 1981 Mar 20;93(6):186-93.
4
[Hypothalamo-hypophyseal amenorrhea. I. The clinical and laboratory manifestations].[下丘脑 - 垂体性闭经。I. 临床及实验室表现]
Ginecol Obstet Mex. 1990 Dec;58:346-53.
5
[Psychosomatically and endocrinologically oriented diagnosis and therapy of the secondary amenorrhea syndrome. Treatment results in 100 amenorrhea patients].继发性闭经综合征的心身与内分泌学导向诊断及治疗。100例闭经患者的治疗结果
Gynakologe. 1982 Dec;15(4):173-89.
6
[Variations of the plasma levels of gonadotrophins (FSH and LH) and of its response to stimulation with gonadotrophin releasing hormone (GnRH) with different plasma levels of prolactin (PRL) in women with the syndrome of galactorrhea-amenorrhea (author's transl)].[溢乳-闭经综合征女性中不同催乳素(PRL)血浆水平下促性腺激素(FSH和LH)的血浆水平变化及其对促性腺激素释放激素(GnRH)刺激的反应(作者译)]
Med Clin (Barc). 1981 Feb 25;76(4):164-8.
7
[Arginine-GnRH-TRH test in patients with primary hypothalamic amenorrhea].[原发性下丘脑性闭经患者的精氨酸-促性腺激素释放激素-促甲状腺激素释放激素试验]
Zentralbl Gynakol. 1985;107(16):996-1002.
8
[Clinical use of Gonadorelin as a diagnostic agent in one- and two-step tests].[促性腺激素释放激素作为诊断剂在一步法和两步法试验中的临床应用]
Zentralbl Gynakol. 1986;108(23):1442-52.
9
Endocrine assessment of post-pill amenorrhoea.避孕药后闭经的内分泌评估。
Proc R Soc Med. 1973 Jun;66(6):567-9. doi: 10.1177/003591577306600631.
10
The value of radioimmunoassay of LH, FSH, and PRL in the diagnosis of secondary amenorrhea.促黄体生成素、促卵泡生成素及泌乳素放射免疫测定在继发性闭经诊断中的价值
Chin Med J (Engl). 1987 Jun;100(6):477-81.

引用本文的文献

1
The effect of danazol on the pituitary function, thyroid function, and mastodynia.达那唑对垂体功能、甲状腺功能及乳房疼痛的影响。
Arch Gynecol. 1980;230(1):3-8. doi: 10.1007/BF02108592.